Global Cellular Therapy in Oncology Pipeline Market: Overview
Cellular therapy is generally known as cytotherapy. It is a process in which cellular material such as T cells are injected into a patient’s body. Cellular therapy is used in the treatment of numerous diseases and disorders. These cellular therapies are primarily used in the treatment of cancer. The increasing number of patients suffering from cancer is creating a need for novel treatment and drugs, which is propelling investments and the research and development (R&D) activities. Growing research activities are increasing the number of pipeline products and are likely to propel growth of the cellular therapy in oncology pipeline market.
The global cellular therapy in oncology pipeline market is segmented on the basis of clinical phase and type of mechanism of action. On the basis of a type of mechanism of action, the global market for cellular therapy in oncology pipeline is segmented into cell surface markers, targeting signaling pathways, and targeting miRNA expression. Of these type of mechanism, targeting signaling pathways segment is dominating the global cellular therapy in oncology pipeline market and expected to remain dominant over the forecast period.
The report on the cellular therapy in oncology pipeline market includes an inclusive study on cellular therapy in oncology. It contains information derived from industrial sources. The report offers information on vendor landscape and studies the prevailing competition on the basis of company history, SWOT analysis, annual turnover, research and development (R&D) activities, mergers and acquisitions (M&A) activities, and new product launches. Moreover, it enlightens about strategies adopted by players in order to gain the competitive edge in the global cellular therapy in oncology pipeline market.
Global Cellular Therapy in Oncology Pipeline Market: Drivers and Restraints
According to the World Health Organization (WHO), nearly 8.2 million people die due to cancer every year. It is also expected to rise further in the coming years. The rising incidence of cancer, coupled with the growing pipeline, is aiding the market’s expansion. Moreover, cell therapy trails are under numerous stages of drug discovery. Growing research on the cell therapies is developing innovative therapies which are fuelling growth of the global cellular therapy in oncology pipeline market.
However, the high cost of drugs and therapies and emerging biosimilars, coupled with stringent regulatory policies, is posing as restraints to the growth of the global cellular therapy in oncology pipeline market.
Global Cellular Therapy in Oncology Pipeline Market - Regional Outlook:
Geographically, the global cellular therapy in oncology pipeline market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Of these regions, North America is dominating the global cellular therapy in oncology pipeline market. This growth of global cellular therapy in oncology pipeline market is attributable to the presence of research infrastructure and higher funding for research coupled with the growing prevalence of cancer. However, Asia Pacific is expected to expand with higher CAGR owing to growing research on the domain and growing prevalence of cancer in the region.
Global Cellular Therapy in Oncology Pipeline Market: Competitive Landscape
Some of the prominent players operating in the global cellular therapy in oncology pipeline market Argos Therapeutics, Biopharma GmbH, CELGENE CORPORATION, Immunocellular Therapeutics, Ltd., and Benitec Biopharma Limited. In order to gain substantial share in the global cellular therapy in oncology pipeline market, these key players are trying to develop cost-effective and highly efficient products.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.